James F. Polewaczyk - Mar 6, 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Stock symbol
IDXX
Transactions as of
Mar 6, 2024
Transactions value $
-$1,102,049
Form type
4
Date filed
3/7/2024, 05:00 PM
Previous filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $156K +755 +7.05% $206.94 11.5K Mar 6, 2024 Direct
transaction IDXX Common Stock Options Exercise $100K +483 +4.21% $206.94 11.9K Mar 6, 2024 Direct
transaction IDXX Common Stock Options Exercise $643K +2.23K +18.63% $288.78 14.2K Mar 6, 2024 Direct
transaction IDXX Common Stock Options Exercise $2.52M +4.64K +32.73% $544.08 18.8K Mar 6, 2024 Direct
transaction IDXX Common Stock Sale -$2.31M -4.13K -21.97% $557.94 14.7K Mar 6, 2024 Direct F1
transaction IDXX Common Stock Sale -$1.84M -3.29K -22.41% $558.88 11.4K Mar 6, 2024 Direct F2
transaction IDXX Common Stock Sale -$380K -680 -5.97% $559.33 10.7K Mar 6, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -755 -100% $0.00* 0 Mar 6, 2024 Common Stock 755 $206.94 Direct F4
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise $0 -483 -100% $0.00* 0 Mar 6, 2024 Common Stock 483 $206.94 Direct F5
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -2.23K -100% $0.00* 0 Mar 6, 2024 Common Stock 2.23K $288.78 Direct F6
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -4.64K -77.29% $0.00 1.36K Mar 6, 2024 Common Stock 4.64K $544.08 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $557.33 to a high of $558.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average price of the shares sold ranging from a low of $558.45 to a high of $559.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $559.51 to a high of $559.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
F5 Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024.
F6 Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
F7 Grant of option to buy 6,003 shares of Issuer common stock that vest in four annual installments beginning February 14, 2022.